Skip to main content

Hematology

HPLC

Overview of Hemoglobin HPLC

  • Definition: High-Performance Liquid Chromatography (HPLC) is a powerful analytical technique used to separate, identify, and quantify different hemoglobin variants in a blood sample.
  • Clinical Significance:
    • Diagnosis of Hemoglobinopathies: Essential for detecting and characterizing hemoglobin variants associated with sickle cell disease, thalassemias, and other hemoglobin disorders
    • Newborn Screening: Used in newborn screening programs to identify infants with hemoglobinopathies
    • Monitoring Glycated Hemoglobin (HbA1c): HPLC is also used to measure HbA1c levels, a key indicator of long-term glycemic control in individuals with diabetes
    • Research Applications: Used in research studies to investigate hemoglobin structure and function
  • Advantages over Hemoglobin Electrophoresis:
    • Higher Resolution: Can separate and quantify a wider range of hemoglobin variants, including those that comigrate on electrophoresis
    • Improved Sensitivity: Can detect small amounts of abnormal hemoglobins
    • Automation: Automated systems are available, reducing manual handling and improving throughput
    • Quantitative Results: Provides accurate quantitative measurements of each hemoglobin type
    • Versatility: Can be used to measure both hemoglobin variants and glycated hemoglobin (HbA1c)
  • Limitations:
    • Higher Cost: More expensive than traditional electrophoresis methods
    • Complexity: Requires trained personnel to operate and maintain the equipment
    • Interferences: Certain substances can interfere with the separation and detection of hemoglobin variants

Principle of Hemoglobin HPLC

  • Separation: Hemoglobin variants are separated based on their interactions with a stationary phase within a column
  • Detection: The separated hemoglobin variants are detected as they elute from the column using spectrophotometry
  • Key Components:
    • Sample: Hemolysate (lysed red blood cells) containing hemoglobin
    • Column: A column packed with a solid stationary phase material (e.g., reversed-phase, ion exchange)
    • Mobile Phase: A liquid solvent that is pumped through the column
      • The composition of the mobile phase (e.g., pH, organic solvent concentration) is carefully controlled to optimize the separation of hemoglobin variants
    • Pump: A high-pressure pump to deliver the mobile phase through the column at a constant flow rate
    • Detector: A spectrophotometer that measures the absorbance of the eluting hemoglobin variants at a specific wavelength (typically 415 nm)
    • Data Acquisition System: A computer system that records and analyzes the detector signal, generating a chromatogram

HPLC Methodologies

  • Ion-Exchange Chromatography:

    • Stationary Phase: A solid material with charged groups (e.g., negatively charged sulfonate groups for cation exchange, positively charged amino groups for anion exchange)
    • Separation Principle: Hemoglobin variants are separated based on their charge interactions with the stationary phase
    • Mobile Phase: A buffer solution with a controlled pH and ionic strength
      • The ionic strength is gradually increased to elute the bound hemoglobin variants
    • Detection: Spectrophotometry at 415 nm
    • Advantages: Good for separating HbA2 and HbF from other hemoglobin variants

  • Reversed-Phase Chromatography:

    • Stationary Phase: A solid material with hydrophobic groups (e.g., C8 or C18 alkyl chains)
    • Separation Principle: Hemoglobin variants are separated based on their hydrophobic interactions with the stationary phase
    • Mobile Phase: A mixture of water and an organic solvent (e.g., acetonitrile or methanol)
      • The organic solvent concentration is gradually increased to elute the bound hemoglobin variants
    • Detection: Spectrophotometry at 415 nm
    • Advantages: High resolution and sensitivity; can be used to separate a wide range of hemoglobin variants

  • Hemoglobin Variant Analysis

    • Sample Preparation: A hemolysate is prepared from EDTA whole blood
    • Injection: A small amount of the hemolysate is injected into the HPLC system
    • Separation: Hemoglobin variants are separated in the column based on their charge or hydrophobicity
    • Detection: As each hemoglobin variant elutes from the column, it passes through the detector, which measures its absorbance at 415 nm
    • Data Analysis: The detector generates a chromatogram, which shows a series of peaks corresponding to the different hemoglobin types
      • The retention time (the time it takes for a hemoglobin variant to elute from the column) is used to identify the hemoglobin type
      • The area under each peak is proportional to the amount of that hemoglobin variant in the sample

  • Glycated Hemoglobin (HbA1c) Analysis

    • Principle: Hemoglobin A1c (HbA1c) is a form of hemoglobin that is glycated (glucose is attached)
      • The amount of HbA1c is proportional to the average blood glucose level over the preceding 2-3 months
    • Sample Preparation: Blood is collected in an EDTA tube and lysed to release the hemoglobin
    • Separation: Glycated and non-glycated hemoglobins are separated in the column
    • Detection: The glycated and non-glycated hemoglobins are detected, and the percentage of HbA1c is calculated

Interferences

  • Elevated Fetal Hemoglobin (HbF):

    • Can interfere with the separation and quantification of other hemoglobin variants, especially HbA2
    • May require special methods to accurately measure HbA2 in the presence of elevated HbF

  • Unstable Hemoglobins:

    • Can degrade during the HPLC process, leading to inaccurate results
    • Use fresh samples and appropriate sample handling techniques

  • Chemical Modifications:

    • Carbamylated hemoglobin (in patients with renal failure) can interfere with HPLC results

  • Lipemia and Turbidity:

    • Can interfere with spectrophotometric detection, leading to inaccurate results
    • Use appropriate sample preparation techniques to remove lipids

  • Certain Hemoglobin Variants:

    • Some rare hemoglobin variants may co-elute with other hemoglobin types, leading to misidentification

Quality Control (QC)

  • Run Controls with Known Hemoglobin Patterns:
    • Include normal and abnormal controls with each HPLC run
    • The control results should fall within established reference ranges
  • Check Reagents and Buffers:
    • Use high-quality reagents and buffers
    • Prepare reagents according to the manufacturer’s instructions
    • Monitor the pH and expiration dates of buffers
  • Maintain the HPLC System:
    • Perform routine maintenance on the HPLC system according to the manufacturer’s recommendations
    • This includes cleaning the column, replacing the mobile phase, and performing preventative maintenance procedures
  • Document All Quality Control Procedures:
    • Record the dates, lot numbers, and results of all quality control procedures

Reporting Results

  • Report the percentage of each hemoglobin type (e.g., HbA, HbA2, HbF, HbS, HbC)
  • Include a visual representation of the chromatogram
  • Provide an interpretation of the results, noting any abnormal findings
  • Correlate the laboratory findings with the patient’s clinical information

Key Terms

  • High-Performance Liquid Chromatography (HPLC): A chromatographic technique used to separate, identify, and quantify different substances in a mixture
  • Mobile Phase: The liquid solvent that is pumped through the column
  • Stationary Phase: The solid material packed into the column that interacts with the analytes
  • Retention Time: The time it takes for an analyte to elute from the column
  • Chromatogram: A graphical representation of the detector signal versus time
  • Glycated Hemoglobin (HbA1c): Hemoglobin that is glycated (glucose is attached)
  • Hemoglobinopathy: A genetic disorder affecting the structure or synthesis of hemoglobin
  • Hemoglobin Variant: An abnormal hemoglobin molecule